The EDC is live today — see what ships now
All studies
NCT07345559From ClinicalTrials.govRecruiting

Personalisation of Mean Arterial Pressure in Adult Patients With Cardiogenic Shock

Prospective, Randomized, Multicenter, Controlled Trial Assessing the Personalization of Mean Arterial Pressure in Adult Patients With Cardiogenic Shock

  • Cardiogenic Shock

At a glance

Phase
Phase not stated
Study type
Interventional
Sponsor
CMC Ambroise Paré
Enrolment target
406
Started
26 March 2026
Main results due
25 July 2029
Study sites
11
Registry updated
29 September 2026

Can you take part?

  • Aged 18 years and over.
  • Open to any sex.
  • You need the condition being studied — healthy volunteers are not accepted.

These are the headline rules only. Every study has a longer list, and whether you are eligible is decided by the research team at the site — never by this page.

Read the full eligibility criteria
Inclusion Criteria:

* Aged ≥18 years
* Cardiogenic shock state, according to the consensus definition,
* SCAI (Society for Cardiovascular Angiography and Interventions) classification ≥ C
* Consent from the patient or close relative / trusted person or emergency inclusion procedure
* Benefiting fromciary of a social security scheme

Exclusion Criteria:

* Catecholamine infusion for more than 24 consecutive hours;
* CVP \< 5 mm Hg at inclusion;
* MAP \> 70 mmHg at inclusion;
* Chronic kidney disease stage G4 (defined by an eGFR between 15-29 ml/min/1.73 m²) or G5 (defined by an eGFR less than 15 ml/min/1.73 m²) according to the KDIGO CKD classification at inclusion;
* Chronic dialysis or presence of renal replacement therapy criteria at inclusion ;
* Recovered cardiopulmonary arrest within 7 days prior to inclusion;
* Patient already on mechanical circulatory support at inclusion before enrollment (patients who receive support after inclusion will not be excluded);
* Primary diagnosis of tamponade, pulmonary embolism, or septic shock;
* Hypersensitivity to norepinephrine tartrate or to any of the following excipients: sodium chloride, hydrochloric acid or sodium hydroxide water for injectable preparations;
* Absence of central venous access;
* Known pregnancy or current breastfeeding;
* Under legal guardianship, curatorship, or judicial protection.

What this study is about

In the sponsor’s own words, from the registry.

Cardiogenic shock is a life-threatening condition characterized by inadequate cardiac output, leading to organ hypoperfusion and high mortality. Maintaining mean arterial pressure (MAP) is crucial, but standard targets may be insufficient due to venous congestion. Central venous pressure (CVP) can help assess effective perfusion pressure. This study investigates whether a personalized MAP target adjusted by CVP improves organ function and survival compared to standard MAP management.

Study sites(11)

  • CHU d'Amiens-Picardie

    Amiens, France

    Not yet recruiting

  • Hôpital Henri Mondor

    Créteil, France

    Recruiting

  • Hôpital Privé Jacques Cartier

    Massy, France

    Not yet recruiting

  • CMC Ambroise Paré - Hartmann

    Neuilly-sur-Seine, France

    Recruiting

  • CHU d'Orléans

    Orléans, France

    Not yet recruiting

  • Hôpital Lariboisière

    Paris, France

    Not yet recruiting

  • Hôpital Cochin

    Paris, France

    Not yet recruiting

  • Clinique NCT + /Saint-Gatien

    Saint-Cyr-sur-Loire, France

    Not yet recruiting

  • Centre Cardiologique du Nord

    Saint-Denis, France

    Not yet recruiting

  • CHRU de Strasbourg

    Strasbourg, France

    Not yet recruiting

  • CHU de Toulouse

    Toulouse, France

    Not yet recruiting

Showing 11 of 11 sites. 2 of the 11 sites on this study are recruiting right now — a site can stop enrolling while the study as a whole is still open.

Source: ClinicalTrials.gov record NCT07345559. Trialion does not run this study, is not paid to refer anyone to it, and cannot enrol you. Eligibility is always decided by the research team at the site.

Not the right study?

Answer three questions and see the studies recruiting near you, in plain language.

Find a study for me
Personalisation of Mean Arterial Pressure in Adult Patients With Cardiogenic Shock | Trialion